Characterizing acyl-carnitine biosignatures for schizophrenia: a longitudinal pre- and post-treatment study

Subjects with schizophrenia have high risks of metabolic abnormalities and bioenergetic dysfunction. Acyl-carnitines involved in bioenergetic pathways provide potential biomarker targets for identifying early changes and onset characteristics in subjects with schizophrenia. We measured 29 acyl-carni...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Bing, Wang, Dongfang, Pan, Zihang, Brietzke, Elisa, McIntyre, Roger S., Musial, Natalie, Mansur, Rodrigo B., Subramanieapillai, Mehala, Zeng, Jing, Huang, Ninghua, Wang, Jingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336814/
https://www.ncbi.nlm.nih.gov/pubmed/30655505
http://dx.doi.org/10.1038/s41398-018-0353-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336814/
https://www.ncbi.nlm.nih.gov/pubmed/30655505
http://dx.doi.org/10.1038/s41398-018-0353-x

Ejemplares similares